Prolor Biotech (PBTH +11.1%) follows up last week's strong gains with a double-digit move up. M.E. Garza attributes the buying to M&A chatter emerging out of a major healthcare conference last week in San Francisco on the strength of the firm's promising drug pipeline.
Prolor Biotech (PBTH +11.1%) follows up last week's strong gains with a double-digit move up....
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs